Search research articles
Contact Us
Filters
Showing results (91-100 of 213) with videos related to
Page
of 22
Sort By:
ESC Heart Failure
|
March 12, 2021
Sex differences in congestive markers in patients hospitalized for acute heart failure
Caroline Espersen, Ross T Campbell, Brian Claggett, et al.
Circulation
|
February 3, 2025
Measuring Representativeness in Clinical Trials
Allen Sanyi, Samuel Byiringiro, Sanaz Dabiri, et al.
European Heart Journal. Acute Cardiovascular Care
|
January 25, 2020
Quantification of pleural effusions on thoracic ultrasound in acute heart failure
Moritz Lindner, Richard Thomas, Brian Claggett, et al.
ESC Heart Failure
|
February 21, 2020
Body mass index and B-lines on lung ultrasonography in chronic and acute heart failure
Philip Brainin, Brian Claggett, Eldrin F Lewis, et al.
Circulation. Heart Failure
|
August 9, 2017
Health-Related Quality of Life Outcomes in PARADIGM-HF
Eldrin F Lewis, Brian L Claggett, John J V McMurray, et al.
Circulation. Heart Failure
|
December 21, 2018
Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction
Senthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
European Journal of Heart Failure
|
April 10, 2026
Spironolactone, Early Acute eGFR Changes, and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from TOPCAT Americas
Iris E Beldhuis, Brian L Claggett, Brendon L Neuen, et al.
International Journal of Cardiology
|
April 10, 2024
Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure
Caroline Espersen, Ross T Campbell, Brian L Claggett, et al.
Circulation. Heart Failure
|
June 22, 2019
Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction
Senthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
Heart (British Cardiac Society)
|
April 22, 2010
Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial
Kent R Nilsson, Sana M Al-Khatib, Yi Zhou, et al.
Page
of 22
Search research articles
Search
Showing results (91-100 of 213) with videos related to
Sort By:
Page
of 22
ESC Heart Failure
|
March 12, 2021
Sex differences in congestive markers in patients hospitalized for acute heart failure
Caroline Espersen, Ross T Campbell, Brian Claggett, et al.
Circulation
|
February 3, 2025
Measuring Representativeness in Clinical Trials
Allen Sanyi, Samuel Byiringiro, Sanaz Dabiri, et al.
European Heart Journal. Acute Cardiovascular Care
|
January 25, 2020
Quantification of pleural effusions on thoracic ultrasound in acute heart failure
Moritz Lindner, Richard Thomas, Brian Claggett, et al.
ESC Heart Failure
|
February 21, 2020
Body mass index and B-lines on lung ultrasonography in chronic and acute heart failure
Philip Brainin, Brian Claggett, Eldrin F Lewis, et al.
Circulation. Heart Failure
|
August 9, 2017
Health-Related Quality of Life Outcomes in PARADIGM-HF
Eldrin F Lewis, Brian L Claggett, John J V McMurray, et al.
Circulation. Heart Failure
|
December 21, 2018
Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction
Senthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
European Journal of Heart Failure
|
April 10, 2026
Spironolactone, Early Acute eGFR Changes, and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction: Insights from TOPCAT Americas
Iris E Beldhuis, Brian L Claggett, Brendon L Neuen, et al.
International Journal of Cardiology
|
April 10, 2024
Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure
Caroline Espersen, Ross T Campbell, Brian L Claggett, et al.
Circulation. Heart Failure
|
June 22, 2019
Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction
Senthil Selvaraj, Brian Claggett, Sanjiv J Shah, et al.
Heart (British Cardiac Society)
|
April 22, 2010
Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial
Kent R Nilsson, Sana M Al-Khatib, Yi Zhou, et al.
Page
of 22